Origin Therapeutics Holdings (XCNQ:ORIG) Interest Expense : C$0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Origin Therapeutics Holdings's interest expense for the three months ended in Jun. 2023 was C$ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Origin Therapeutics Holdings's Operating Income for the three months ended in Jun. 2023 was C$ -0.09 Mil. Origin Therapeutics Holdings's Interest Expense for the three months ended in Jun. 2023 was C$ 0.00 Mil. Origin Therapeutics Holdings has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Origin Therapeutics Holdings Interest Expense Historical Data

The historical data trend for Origin Therapeutics Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Interest Expense Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Interest Expense

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Interest Expense	Get a 7-Day Free Trial				-	-	-	-	-

Origin Therapeutics Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Origin Therapeutics Holdings (XCNQ:ORIG) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Origin Therapeutics Holdings's Interest Expense for the three months ended in Jun. 2023 was C$0.00 Mil. Its Operating Income for the three months ended in Jun. 2023 was C$-0.09 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2023 was C$0.00 Mil.

Origin Therapeutics Holdings's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Origin Therapeutics Holdings had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Origin Therapeutics Holdings Inc has no debt.